论文部分内容阅读
作者采用多种药物综合治疗36例头颈部晚期癌。在24例有价值的病例中,有19例肿瘤缩小50%以上,1例缩小25%,4例无反应。作者认为此种疗法应当用在这些癌症的较早的时期,作为放疗或手术的辅助疗法较好。作者出于医学道德,只选择晚期不能手术或放疗的头颈部癌症病人进行试验。可供分析的有价值的病人的指标是:1.病变可作客观测量;2.至少给了三个疗程的治疗;3.没有同时给其它抗肿瘤治疗。
The author used a variety of drugs to treat 36 cases of advanced head and neck cancer. Among 24 valuable cases, there were 19 cases of tumor shrinking by more than 50%, 1 case of shrinking by 25%, and 4 cases had no response. The authors believe that this type of therapy should be used earlier in these cancers as an adjunct to radiotherapy or surgery. For medical ethics, the author chose only patients with head and neck cancer who were unable to undergo surgery or radiotherapy at the end of the trial. The valuable patient indicators that can be analyzed are: 1. The lesions can be measured objectively; 2. At least three courses of treatment are given; 3. No other anti-tumor treatments are given at the same time.